Cargando…
Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics
Abnormalities in the gastrointestinal (GI) tract of Parkinson’s disease (PD) sufferers were first reported over 200 years ago; however, the extent and role of GI dysfunction in PD disease progression is still unknown. GI dysfunctions, including dysphagia, gastroparesis, and constipation, are amongst...
Autores principales: | Han, Myat Noe, Finkelstein, David I., McQuade, Rachel M., Diwakarla, Shanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875119/ https://www.ncbi.nlm.nih.gov/pubmed/35207632 http://dx.doi.org/10.3390/jpm12020144 |
Ejemplares similares
-
A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson’s Disease
por: O’Day, Chelsea, et al.
Publicado: (2022) -
Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation
por: McQuade, Rachel M., et al.
Publicado: (2022) -
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
por: Diwakarla, Shanti, et al.
Publicado: (2021) -
The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson’s disease
por: McQuade, Rachel M., et al.
Publicado: (2021) -
Co-treatment With BGP-15 Exacerbates 5-Fluorouracil-Induced Gastrointestinal Dysfunction
por: McQuade, Rachel M., et al.
Publicado: (2019)